Hinge Health (US.HNGE)
Capital Allocation Audit · Period: 2023 – 2026
Key Metrics
US.HNGE · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 96.4% | ↑ |
| ROE | 30.5% | → |
| Cash Conversion | 126.7% | ↑ |
| D/E Ratio | 0.02 | → |
| Gross Margin | 84.6% | → |
US.HNGE (Hinge Health) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY ---------------------------- FCF Conversion 96.4% ↑ ROE 30.5% → Cash Conversion 126.7% ↑ D/E Ratio 0.02 → Gross Margin 84.6% →
Key Metrics
US.HNGE (Hinge Health) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY----------------------------FCF Conversion 96.4% ↑ROE 30.5% →Cash Conversion 126.7% ↑D/E Ratio 0.02 →Gross Margin 84.6% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies